TY - JOUR
T1 - De novo and inherited private variants in MAP1B in periventricular nodular heterotopia
AU - for the Epi4K Consortium
AU - Epilepsy Phenome/Genome Project
AU - Heinzen, Erin L.
AU - O'Neill, Adam C.
AU - Zhu, Xiaolin
AU - Allen, Andrew S.
AU - Bahlo, Melanie
AU - Chelly, Jamel
AU - Chen, Ming Hui
AU - Dobyns, William B.
AU - Freytag, Saskia
AU - Guerrini, Renzo
AU - Leventer, Richard J.
AU - Poduri, Annapurna
AU - Robertson, Stephen P.
AU - Walsh, Christopher A.
AU - Zhang, Mengqi
N1 - Publisher Copyright:
© 2018 Heinzen et al. http://creativecommons.org/licenses/by/4.0/
PY - 2018/5
Y1 - 2018/5
N2 - Periventricular nodular heterotopia (PVNH) is a malformation of cortical development commonly associated with epilepsy. We exome sequenced 202 individuals with sporadic PVNH to identify novel genetic risk loci. We first performed a trio-based analysis and identified 219 de novo variants. Although no novel genes were implicated in this initial analysis, PVNH cases were found overall to have a significant excess of nonsynonymous de novo variants in intolerant genes (p = 3.27x10-7), suggesting a role for rare new alleles in genes yet to be associated with the condition. Using a gene-level collapsing analysis comparing cases and controls, we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the MAP1B variant was inherited from a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate MAP1B in PVNH. More broadly, our findings suggest that detrimental mutations likely arising in immediately preceding generations with incomplete penetrance may also be responsible for some apparently sporadic diseases.
AB - Periventricular nodular heterotopia (PVNH) is a malformation of cortical development commonly associated with epilepsy. We exome sequenced 202 individuals with sporadic PVNH to identify novel genetic risk loci. We first performed a trio-based analysis and identified 219 de novo variants. Although no novel genes were implicated in this initial analysis, PVNH cases were found overall to have a significant excess of nonsynonymous de novo variants in intolerant genes (p = 3.27x10-7), suggesting a role for rare new alleles in genes yet to be associated with the condition. Using a gene-level collapsing analysis comparing cases and controls, we identified a genome-wide significant signal driven by four ultra-rare loss-of-function heterozygous variants in MAP1B, including one de novo variant. In at least one instance, the MAP1B variant was inherited from a parent with previously undiagnosed PVNH. The PVNH was frontally predominant and associated with perisylvian polymicrogyria. These results implicate MAP1B in PVNH. More broadly, our findings suggest that detrimental mutations likely arising in immediately preceding generations with incomplete penetrance may also be responsible for some apparently sporadic diseases.
UR - https://www.scopus.com/pages/publications/85048231384
UR - https://www.scopus.com/pages/publications/85048231384#tab=citedBy
U2 - 10.1371/journal.pgen.1007281
DO - 10.1371/journal.pgen.1007281
M3 - Article
C2 - 29738522
AN - SCOPUS:85048231384
SN - 1553-7390
VL - 14
JO - PLoS genetics
JF - PLoS genetics
IS - 5
M1 - e1007281
ER -